1- Drug development and clinical
2- Apply for approval and deal with FDA
3- Market the drug.
Not all small caps have all above and they mostly lack one or two.
Sooner or later, some companies will realize the value of SPPI.
Phase 1: Short in the morning, keep the price high enough to short enough shares.
Phase 2: Time to push the price down with for low of the day
Phase 3: Cover the positions which cause the price to recover some before close.
In addition, I do not think hedge funds pay them on weekends even though they try to push their luck.
May be they do it free on weekends.
wow! lome70 is running out of option. Talking about misleading investors on a public board daily with help of his other IDs and hedge fund club. How he has dared to threaten others with court!?. What a jock! At least I my Sunday laugh.
If the generic FUSILEV should be kept frozen then the cost of it will not be cheap plus all the headaches of storage.
This generic drug is the most stupidest one any company can do.
Sandoz is doing for publicity and manipulation of SPPI with help of some hedge funds who are manipulating the stock.
No need to get in details but look at overall picture, 5 approved drugs, promising pipeline, growing sale and revenue, low market cap and PPS. This is scary for any short with brain.
They may be happy with their account now but in a few months same accounts will shrink significantly unless they start to cover as soon as possible.
I noticed a lot nervous shorts who try to put a negative spin on this $6 stock. If it was $60 stock with over $2B market cap then people pay attention. However, the stock is extremely cheap $6, even any other new company with no drug or even one drug in phase 1 is trading higher.
SPPI pipeline worth over 1B.
Why are shorts not scared yet? give it some time and they will be looking for a place to hide after losing all their life saving.
Some funds that needed to move out they did in past 2 days and now new funds are joining or increasing their holding. Shorts will be crushed on Monday.
5 approved drugs
$185 m sale and growing
strong pipeline with drugs in phase III and II
good cash position to support the growth
very low market cap
Where you want from investing when you see companies like SPPI? It is not going up overnight and you may see it doubled and tripled in a few years.
Do not answer to him. Let him and his other IDs to be isolated.
If he is dishonest then there is no reason to argue with him.
Remember that SPPI is spending money for growth and if this was not the case then it could have positive income with $200 m revenue.
Do not fall for shorts tricks. This is over $1B company with current approved drugs and minimum $500 m for its pipeline.
Excellent point about Hong Kong. If middle eastern patients go to Europe and pay dear money to live a few days longer then Chinese patients from mainland will go to Hong Kong where they have the same language and they feel at home to be treated.
After all, do not respond to shorts who are here for an agenda.
I think you need to learn a few things before you throw things mindlessly.
When you get this kind of shares then yor brokerage needs to hold some taxes and usually sells some shares for this purpose.
Next lesson won't be free.
An investor should know when to exit with profit or without it to cut the losses.
SPPI with 5 approved products, and several in phase III and phase II and one waiting for approval.
Rev of $200 m yet the market cap is below $400 m and price is low $6. This is the best opportunity to gain.
Unfortunately, some investors are focus on some negative.
Compare this company to many others in the sector. Show me one with same revenue and pipeline that it is not traded below $15.